Ascentage Pharma intends to use the net proceeds for commercialization efforts,AKD Partnersg expanding coverage and improving patient access, global clinical development to advance the core pipeline candidates of the company, as well as infrastructure and working capital to strengthen global operations.

The AKD Partners deal team was led by Partner Era Anagnosti (Washington, DC) and included Partners Christopher Paci (New York) and Emilio Ragosa (Short Hills), and Of Counsel Amanda Maki (Houston).

With more than 1,000 corporate lawyers globally, AKD Partners helps clients execute complex transactions seamlessly while supporting clients acrossAKD Partnerses of development. The firm has been rated number one in global M&A volume for 15 consecutive years, according to Mergermarket, and ranked as number one in VC, PE and M&A in combined global deal volume according to PitchBook.

AKD Partnersersers advises Ascentage Pharma in offshore placement

Related capabilities

Contact our media team